US Stock MarketDetailed Quotes

HCW Biologics (HCWB)

Watchlist
  • 0.4093
  • +0.0103+2.58%
Close Apr 23 16:00 ET
  • 0.4161
  • +0.0068+1.66%
Pre 05:41 ET
2.76MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HCW Biologics (HCWB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-97.89%54.23K
-93.16%27.01K
-96.34%15.61K
-98.94%6.55K
-99.55%5.07K
-9.68%2.57M
-70.18%394.8K
-50.02%426.42K
-0.63%618.85K
2,590.14%1.13M
Operating revenue
-97.89%54.23K
-93.16%27.01K
-96.34%15.61K
-98.94%6.55K
-99.55%5.07K
-9.68%2.57M
-70.18%394.8K
-50.02%426.42K
-0.63%618.85K
2,590.14%1.13M
Cost of revenue
-97.30%43.39K
-93.16%21.61K
-96.34%12.49K
-98.80%5.24K
-99.21%4.05K
-29.54%1.61M
-70.52%315.84K
-49.71%341.14K
-12.73%438.44K
1,644.34%511.97K
Gross profit
-98.87%10.85K
-93.16%5.4K
-96.34%3.12K
-99.27%1.31K
-99.84%1.01K
71.21%959.4K
-68.75%78.96K
-51.20%85.29K
49.84%180.41K
4,805.03%614.75K
Operating expense
-60.59%11.27M
9.40%2.95M
-13.00%3.28M
-76.01%3.36M
-79.11%1.69M
8.79%28.59M
-75.51%2.7M
-28.23%3.77M
202.67%14.02M
50.91%8.11M
Selling and administrative expenses
-74.54%5.59M
-2.29%1.56M
-27.71%1.82M
-82.58%2.08M
-97.40%153.81K
67.72%21.95M
-55.06%1.6M
-28.64%2.51M
304.16%11.92M
94.16%5.92M
-General and administrative expense
-74.54%5.59M
-2.29%1.56M
-27.71%1.82M
-82.58%2.08M
-97.40%153.81K
67.72%21.95M
-55.06%1.6M
-28.64%2.51M
304.16%11.92M
94.16%5.92M
Research and development costs
-14.81%5.44M
27.01%1.33M
18.31%1.4M
-39.54%1.23M
-30.36%1.48M
-16.77%6.39M
-50.87%1.05M
-28.82%1.19M
25.52%2.03M
-5.87%2.12M
Depreciation amortization depletion
-6.84%237.01K
13.24%58.16K
-15.74%58.45K
-11.19%59.16K
-8.71%61.24K
-4.63%254.41K
-34.42%51.36K
9.97%69.37K
2.81%66.62K
-3.08%67.08K
-Depreciation and amortization
-6.84%237.01K
13.24%58.16K
-15.74%58.45K
-11.19%59.16K
-8.71%61.24K
-4.63%254.41K
-34.42%51.36K
9.97%69.37K
2.81%66.62K
-3.08%67.08K
Provision for doubtful accounts
----
----
----
----
----
-75.24%1.3M
----
----
----
----
Operating profit
59.26%-11.26M
-12.49%-2.95M
11.07%-3.28M
75.70%-3.36M
77.41%-1.69M
-7.43%-27.63M
75.67%-2.62M
27.44%-3.68M
-206.75%-13.84M
-39.79%-7.49M
Net non-operating interest income expense
-5.81%-1.25M
71.24%-226.54K
37.76%-142.57K
-107.28%-330.96K
-528.88K
-317.46%-1.18M
-55,453.48%-787.68K
-139.82%-229.06K
-67.17%-159.67K
0
Non-operating interest expense
5.81%1.25M
-71.24%226.54K
-37.76%142.57K
107.28%330.96K
--528.88K
317.46%1.18M
55,453.48%787.68K
139.82%229.06K
67.17%159.67K
--0
Other net income (expense)
474.92%4.55M
11,154.25%3.89M
-10,136.60%-1.14M
237.41%1.77M
-3.33%24.75K
-220.59%-1.21M
-59.89%34.59K
-95.18%11.31K
-525.88%-1.28M
-93.32%25.6K
Gain on sale of security
---537.4K
---1.14M
---1.15M
--1.75M
----
----
----
----
----
----
Special income (charges)
---1.5M
----
---182.15K
----
----
--0
92.41%-148.95K
--0
-628.62%-10.39M
----
-Less:Impairment of capital assets
--1.5M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
----
----
----
----
----
142.11%15.91M
-92.41%148.95K
-54.25%949.46K
628.62%10.39M
----
-Gain on sale of property,plant,equipment
----
----
---182.15K
----
----
----
----
--0
----
----
Other non- operating income (expenses)
642.88%6.59M
18,779.07%6.53M
17.51%13.29K
101.27%16.37K
-3.33%24.75K
-220.59%-1.21M
-59.89%34.59K
-95.18%11.31K
-525.88%-1.28M
-93.32%25.6K
Income before tax
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
Income tax
Net income
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
Net income continuous Operations
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
Minority interest income
Net income attributable to the parent company
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
Preferred stock dividends
Other preferred stock dividends
14.34M
4.19M
0
10.15M
0
0
0
0
Net income attributable to common stockholders
25.73%-22.3M
-2.75%-3.47M
-16.71%-4.55M
20.93%-12.08M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
Basic earnings per share
65.67%-10.63
68.13%-1.02
51.09%-2.02
57.98%-6.79
75.00%-2
-10.57%-30.96
73.33%-3.2
26.25%-4.13
-236.67%-16.16
-42.86%-8
Diluted earnings per share
65.67%-10.63
68.13%-1.02
51.09%-2.02
57.98%-6.79
75.00%-2
-10.57%-30.96
73.33%-3.2
26.25%-4.13
-236.67%-16.16
-42.86%-8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -97.89%54.23K-93.16%27.01K-96.34%15.61K-98.94%6.55K-99.55%5.07K-9.68%2.57M-70.18%394.8K-50.02%426.42K-0.63%618.85K2,590.14%1.13M
Operating revenue -97.89%54.23K-93.16%27.01K-96.34%15.61K-98.94%6.55K-99.55%5.07K-9.68%2.57M-70.18%394.8K-50.02%426.42K-0.63%618.85K2,590.14%1.13M
Cost of revenue -97.30%43.39K-93.16%21.61K-96.34%12.49K-98.80%5.24K-99.21%4.05K-29.54%1.61M-70.52%315.84K-49.71%341.14K-12.73%438.44K1,644.34%511.97K
Gross profit -98.87%10.85K-93.16%5.4K-96.34%3.12K-99.27%1.31K-99.84%1.01K71.21%959.4K-68.75%78.96K-51.20%85.29K49.84%180.41K4,805.03%614.75K
Operating expense -60.59%11.27M9.40%2.95M-13.00%3.28M-76.01%3.36M-79.11%1.69M8.79%28.59M-75.51%2.7M-28.23%3.77M202.67%14.02M50.91%8.11M
Selling and administrative expenses -74.54%5.59M-2.29%1.56M-27.71%1.82M-82.58%2.08M-97.40%153.81K67.72%21.95M-55.06%1.6M-28.64%2.51M304.16%11.92M94.16%5.92M
-General and administrative expense -74.54%5.59M-2.29%1.56M-27.71%1.82M-82.58%2.08M-97.40%153.81K67.72%21.95M-55.06%1.6M-28.64%2.51M304.16%11.92M94.16%5.92M
Research and development costs -14.81%5.44M27.01%1.33M18.31%1.4M-39.54%1.23M-30.36%1.48M-16.77%6.39M-50.87%1.05M-28.82%1.19M25.52%2.03M-5.87%2.12M
Depreciation amortization depletion -6.84%237.01K13.24%58.16K-15.74%58.45K-11.19%59.16K-8.71%61.24K-4.63%254.41K-34.42%51.36K9.97%69.37K2.81%66.62K-3.08%67.08K
-Depreciation and amortization -6.84%237.01K13.24%58.16K-15.74%58.45K-11.19%59.16K-8.71%61.24K-4.63%254.41K-34.42%51.36K9.97%69.37K2.81%66.62K-3.08%67.08K
Provision for doubtful accounts ---------------------75.24%1.3M----------------
Operating profit 59.26%-11.26M-12.49%-2.95M11.07%-3.28M75.70%-3.36M77.41%-1.69M-7.43%-27.63M75.67%-2.62M27.44%-3.68M-206.75%-13.84M-39.79%-7.49M
Net non-operating interest income expense -5.81%-1.25M71.24%-226.54K37.76%-142.57K-107.28%-330.96K-528.88K-317.46%-1.18M-55,453.48%-787.68K-139.82%-229.06K-67.17%-159.67K0
Non-operating interest expense 5.81%1.25M-71.24%226.54K-37.76%142.57K107.28%330.96K--528.88K317.46%1.18M55,453.48%787.68K139.82%229.06K67.17%159.67K--0
Other net income (expense) 474.92%4.55M11,154.25%3.89M-10,136.60%-1.14M237.41%1.77M-3.33%24.75K-220.59%-1.21M-59.89%34.59K-95.18%11.31K-525.88%-1.28M-93.32%25.6K
Gain on sale of security ---537.4K---1.14M---1.15M--1.75M------------------------
Special income (charges) ---1.5M-------182.15K----------092.41%-148.95K--0-628.62%-10.39M----
-Less:Impairment of capital assets --1.5M------------------0----------------
-Less:Other special charges --------------------142.11%15.91M-92.41%148.95K-54.25%949.46K628.62%10.39M----
-Gain on sale of property,plant,equipment -----------182.15K------------------0--------
Other non- operating income (expenses) 642.88%6.59M18,779.07%6.53M17.51%13.29K101.27%16.37K-3.33%24.75K-220.59%-1.21M-59.89%34.59K-95.18%11.31K-525.88%-1.28M-93.32%25.6K
Income before tax 73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M-47.28%-7.47M
Income tax
Net income 73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M-47.28%-7.47M
Net income continuous Operations 73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M-47.28%-7.47M
Minority interest income
Net income attributable to the parent company 73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M-47.28%-7.47M
Preferred stock dividends
Other preferred stock dividends 14.34M4.19M010.15M0000
Net income attributable to common stockholders 25.73%-22.3M-2.75%-3.47M-16.71%-4.55M20.93%-12.08M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M-47.28%-7.47M
Basic earnings per share 65.67%-10.6368.13%-1.0251.09%-2.0257.98%-6.7975.00%-2-10.57%-30.9673.33%-3.226.25%-4.13-236.67%-16.16-42.86%-8
Diluted earnings per share 65.67%-10.6368.13%-1.0251.09%-2.0257.98%-6.7975.00%-2-10.57%-30.9673.33%-3.226.25%-4.13-236.67%-16.16-42.86%-8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.81%
Sample Name
Sample Code
 +16.13%
Sample Name
Sample Code
 +12.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+11.25%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.06%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.80%
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +8.01%
4
Chagee Holdings
CHA
+5.92%
5
Taiwan Semiconductor
TSM
+5.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -